These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14585156)

  • 1. PAR-2: structure, function and relevance to human diseases of the gastric mucosa.
    Kawabata A
    Expert Rev Mol Med; 2002 Jul; 4(16):1-17. PubMed ID: 14585156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PAR (protease-activated receptor) as a novel target for development of gastric mucosal cytoprotective drugs].
    Kawabata A; Kuroda R
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):85P-87P. PubMed ID: 12491789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roles of protease-activated receptor-2 (PAR-2), a G protein-coupled receptor, in modulation of exocrine gland functions].
    Nishikawa H
    Yakugaku Zasshi; 2006 Jul; 126(7):481-8. PubMed ID: 16819269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiological functions of protease-activated receptor-2].
    Kawabata A
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):411-20. PubMed ID: 12835535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.
    Kawabata A; Oono Y; Yonezawa D; Hiramatsu K; Inoi N; Sekiguchi F; Honjo M; Hirofuchi M; Kanke T; Ishiwata H
    Br J Pharmacol; 2005 Jan; 144(2):212-9. PubMed ID: 15655521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of proteinase-activated receptor-2 on cyclooxygenase-2 expression in H. pylori-infected gastric epithelial cells.
    Seo JH; Kim KH; Kim H
    Ann N Y Acad Sci; 2007 Jan; 1096():29-36. PubMed ID: 17405913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection.
    Kawabata A; Kinoshita M; Nishikawa H; Kuroda R; Nishida M; Araki H; Arizono N; Oda Y; Kakehi K
    J Clin Invest; 2001 Jun; 107(11):1443-50. PubMed ID: 11390426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of agonists/antagonists for protease-activated receptors (PARs) and the possible therapeutic application to gastrointestinal diseases].
    Sekiguchi F
    Yakugaku Zasshi; 2005 Jun; 125(6):491-8. PubMed ID: 15930817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-activating peptides for PAR-1 and PAR-2 relax rat gastric artery via multiple mechanisms.
    Kawabata A; Nakaya Y; Ishiki T; Kubo S; Kuroda R; Sekiguchi F; Kawao N; Nishikawa H; Kawai K
    Life Sci; 2004 Oct; 75(22):2689-702. PubMed ID: 15369704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.
    Kawao N; Sakaguchi Y; Tagome A; Kuroda R; Nishida S; Irimajiri K; Nishikawa H; Kawai K; Hollenberg MD; Kawabata A
    Br J Pharmacol; 2002 Mar; 135(5):1292-6. PubMed ID: 11877338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor 2 and gut permeability: a review.
    Bueno L; Fioramonti J
    Neurogastroenterol Motil; 2008 Jun; 20(6):580-7. PubMed ID: 18482083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase-activated receptor 2 (PAR-2) in gastrointestinal and pancreatic pathophysiology, inflammation and neoplasia.
    Søreide K
    Scand J Gastroenterol; 2008 Aug; 43(8):902-9. PubMed ID: 19086162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptor-2-mediated contraction of urinary bladder is enhanced in cyclophosphamide-treated rats.
    Nakahara T; Kubota Y; Saito M; Sakamoto K; Ishii K
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):212-9. PubMed ID: 14673513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2 as a potential therapeutic target.
    Kanke T; Takizawa T; Kabeya M; Kawabata A
    J Pharmacol Sci; 2005 Jan; 97(1):38-42. PubMed ID: 15655295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of ion transport in mammalian airways by protease activated receptors type 2 (PAR-2).
    Kunzelmann K; Sun J; Markovich D; König J; Mürle B; Mall M; Schreiber R
    FASEB J; 2005 Jun; 19(8):969-70. PubMed ID: 15809358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal functions of proteinase-activated receptors.
    Kawabata A
    Life Sci; 2003 Dec; 74(2-3):247-54. PubMed ID: 14607252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracellular carboxyl tail of the PAR-2 receptor controls intracellular signaling and cell death.
    Zhu Z; Stricker R; Li Ry; Zündorf G; Reiser G
    Cell Tissue Res; 2015 Mar; 359(3):817-27. PubMed ID: 25519044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats.
    Kawabata A; Nakaya Y; Kuroda R; Wakisaka M; Masuko T; Nishikawa H; Kawai K
    Br J Pharmacol; 2003 Sep; 140(2):247-54. PubMed ID: 12970102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of protease-activated receptor-2 in inflammation, and its possible implications as a putative mediator of periodontitis.
    Holzhausen M; Spolidorio LC; Vergnolle N
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():177-80. PubMed ID: 15962119
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.